Intuitive Surgical, Inc. (NASDAQ:ISRG)‘s stock had its “hold” rating reaffirmed by equities research analysts at Canaccord Genuity in a note issued to investors on Wednesday. They currently have a $1,000.00 price objective on the medical equipment provider’s stock, up from their prior price objective of $870.00. Canaccord Genuity’s price objective would suggest a potential upside of 5.83% from the stock’s current price.

Other research analysts have also recently issued reports about the company. Royal Bank Of Canada reissued a “hold” rating and set a $1,000.00 price objective on shares of Intuitive Surgical in a report on Friday, July 21st. Morgan Stanley restated an “overweight” rating and issued a $1,070.00 target price (up from $950.00) on shares of Intuitive Surgical in a research note on Tuesday. Zacks Investment Research upgraded Intuitive Surgical from a “hold” rating to a “strong-buy” rating and set a $1,067.00 target price for the company in a research note on Tuesday. Stifel Nicolaus raised their target price on Intuitive Surgical from $800.00 to $850.00 and gave the company a “buy” rating in a research note on Wednesday, April 19th. Finally, Goldman Sachs Group, Inc. (The) assumed coverage on Intuitive Surgical in a research note on Tuesday, May 16th. They issued a “buy” rating and a $1,000.00 target price for the company. Six equities research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the company. The stock presently has an average rating of “Buy” and an average price target of $980.03.

Intuitive Surgical (NASDAQ:ISRG) traded up 0.03% during trading on Wednesday, hitting $945.18. 39,567 shares of the stock traded hands. The company has a 50-day moving average price of $935.86 and a 200 day moving average price of $809.08. Intuitive Surgical has a one year low of $610.71 and a one year high of $974.66. The stock has a market cap of $35.11 billion, a PE ratio of 45.27 and a beta of 0.39.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, July 20th. The medical equipment provider reported $5.95 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $5.79 by $0.16. The company had revenue of $756.20 million during the quarter, compared to analysts’ expectations of $724.51 million. Intuitive Surgical had a return on equity of 15.99% and a net margin of 28.44%. The business’s revenue was up 12.8% on a year-over-year basis. During the same period last year, the business earned $5.62 earnings per share. Analysts expect that Intuitive Surgical will post $23.86 earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: This article was posted by American Banking News and is the property of of American Banking News. If you are reading this article on another domain, it was stolen and republished in violation of U.S. & international copyright and trademark laws. The original version of this article can be accessed at https://www.americanbankingnews.com/2017/07/26/intuitive-surgical-inc-nasdaqisrg-given-hold-rating-at-canaccord-genuity.html.

In other Intuitive Surgical news, SVP Curet Myriam sold 1,202 shares of the business’s stock in a transaction that occurred on Tuesday, July 25th. The stock was sold at an average price of $950.20, for a total value of $1,142,140.40. Following the sale, the senior vice president now owns 1,428 shares in the company, valued at approximately $1,356,885.60. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Marshall Mohr sold 8,950 shares of the business’s stock in a transaction that occurred on Thursday, April 27th. The shares were sold at an average price of $835.89, for a total value of $7,481,215.50. Following the completion of the sale, the chief financial officer now owns 6,422 shares in the company, valued at approximately $5,368,085.58. The disclosure for this sale can be found here. Insiders sold a total of 28,473 shares of company stock worth $25,167,633 in the last 90 days. Company insiders own 2.50% of the company’s stock.

Large investors have recently added to or reduced their stakes in the stock. Brown Advisory Securities LLC boosted its stake in Intuitive Surgical by 1.4% in the first quarter. Brown Advisory Securities LLC now owns 2,247 shares of the medical equipment provider’s stock valued at $1,722,000 after buying an additional 31 shares during the last quarter. Vident Investment Advisory LLC boosted its stake in Intuitive Surgical by 137.0% in the first quarter. Vident Investment Advisory LLC now owns 9,572 shares of the medical equipment provider’s stock valued at $7,337,000 after buying an additional 5,534 shares during the last quarter. Marshall Wace North America L.P. purchased a new stake in Intuitive Surgical during the first quarter valued at approximately $9,596,000. Credit Suisse AG boosted its stake in Intuitive Surgical by 12.1% in the first quarter. Credit Suisse AG now owns 111,246 shares of the medical equipment provider’s stock valued at $85,268,000 after buying an additional 11,965 shares during the last quarter. Finally, Forte Capital LLC ADV boosted its stake in Intuitive Surgical by 10.6% in the first quarter. Forte Capital LLC ADV now owns 2,562 shares of the medical equipment provider’s stock valued at $1,964,000 after buying an additional 245 shares during the last quarter. Hedge funds and other institutional investors own 97.56% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.

Analyst Recommendations for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.